INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 915
08/08/2025
Comentaris i suggeriments
Noves_convos
Cercador de convocatòries
Projectes
Termini exhaurit
FUNDACIÓN LUCHA CONTRA LA CEGUERA (FUNDALUCE)
Per al finançament d'un projecte d'investigació sobre possibles estratègies terapèutiques concretes en el camp de les Distròfies Hereditàries de Retina (DHR)
 
Termini exhaurit
LEO FOUNDATION
LEO Foundation ‘Open competition grants’ are given to support the best dermatology research projects worldwide.
 
Termini exhaurit
AMERICAN SOCIETY OF CLINICAL ONCOLOGY
The Conquer Cancer Career Development Award (CDA) provides funding to clinical investigators who have received their initial faculty appointment and are establishing an independent research career in clinical oncology. This is a mentored award, and the research project is conducted under the guidance of an experienced mentor in the proposed research area. Applications in all areas of cancer research are accepted from U.S. and international applicants
 
Altres
Termini exhaurit
COST (EUROPEAN COOPERATION IN SCIENCE AND TECHNOLOGY)
COST actions are a Pan-European networking instrument that allows researchers to develop jointly their ideas and new initiatives in a field or topic of common interest. It supports Meetings, Conferences, Workshops, Short-term scientific exchanges, Training schools and Dissemination Activities.
 
Borses de viatge
Termini exhaurit
EUROPEAN RESPIRATORY SOCIETY
1-3 months fellowships for scientists, physicians or qualified allied health professionals, in the early stage of their career, going to another European or overseas country.
 
Termini exhaurit
GENETICS SOCIETY OF AMERICA
 
Premis
Termini exhaurit
FPdGI - FUNDACIÓ PRINCESA DE GIRONA
El propòsit d’aquesta categoria (Recerca Científica) és premiar la trajectòria de joves científics (inclosos els que treballin en el camp de les ciències humanes i socials) amb experiències o projectes de recerca destacats en la seva disciplina, emprenedors, innovadors i amb un potencial elevat de desenvolupament futur.
 
Termini exhaurit
FCRi - FUNDACIÓ CATALANA PER A LA RECERCA I LA INNOVACIÓ
Aquests guardons reconeixen i reflecteixen les diverses facetes tant de l’activitat investigadora com de les iniciatives de comunicació i divulgació científica, de mecenatge i la col·laboració científica publicoprivada en projectes per a la Recerca i la Innovació a Catalunya.
 
Termini exhaurit
JOHN WILEY & SONS LIMITED
The Wiley Prize in Biomedical Sciences is intended to recognize breakthrough research in pure or applied life science research that is distinguished by its excellence, originality, and impact on our understanding of biological systems and processes.
 
Recursos Humans
Termini exhaurit
BOEHRINGER INGELHEIM FONDS
The Boehringer Ingelheim Fonds (BIF) awards PhD fellowships of 2 to 3.5 years to outstanding junior scientists worldwide who wish to pursue an ambitious PhD project in basic biomedical research in an internationally leading laboratory.
 
Termini exhaurit
AVHF - ALEXANDER VON HUMBOLDT FOUNDATION
Fellowships for highly-qualified scientists and scholars from abroad, from all disciplines, who completed their doctorates less than four years ago, to spend extended periods of research (6-24 months) in Germany.
 
 
 
Informació últil
 
 No hi ha novetats
 
 
Convos_prop_tancament
Projectes
Termini exhaurit
LEO FOUNDATION
LEO Foundation ‘Open competition grants’ are given to support the best dermatology research projects worldwide.
 
Termini exhaurit
FONDATION LEDUCQ
Internationally collaborative basic, translational, and clinical research in cardiovascular and neurovascular disease involving two network coordinators from different continents.
 
Termini exhaurit
FONDATION JEROME LEJEUNE
Support fundamental, translational and clinical research projects that will strengthen the understanding, deepen the knowledge and/or will explore new therapeutic approaches for Down syndrome and other genetic diseases with intellectual disability.
 
Termini exhaurit
EUROPEAN HEMATOLOGY ASSOCIATION
1-year grant intended to support basic and translational early career researchers in hematology and allow them to test a high-risk but potentially high impact idea that is lacking solid preliminary data.
 
Termini exhaurit
ESCMID - EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES
ESCMID Research Grants help in nurturing the next generation of researchers starting out in CM and ID, marking an important start in their journey of research funding. These grants offer a unique opportunity to explore Bacterial Infections & Diseases during even years and Fungal/Viral/Parasitic Infections & Diseases during odd years.
 
Termini exhaurit
THE MARK FOUNDATION FOR CANCER RESEARCH
Collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer.
 
Termini exhaurit
EUROPEAN HEMATOLOGY ASSOCIATION
Funding for collaboration between two independent research groups in basic/translational hematology research, that are located in two different European countries
 
Termini exhaurit
SPRINGER NATURE LIMITED
One-year research projects that advance understanding of the impact of the small intestine microbiome on human health.
 
Termini exhaurit
PFIZER INC
Pfizer supports Investigator Sponsored Research (ISR) projects that advance medical and scientific knowledge about our therapies.
 
Termini exhaurit
FUNDACIÓN RAMÓN ARECES
Té com a objectiu fonamental el foment de la investigació científica i tècnica d'excel·lència a Espanya mitjançant ajudes de recerca, formació de joves investigadors i difusió i desenvolupament de l'educació i de la cultura científica en general.
 
Termini exhaurit
FUNDACIÓN RAMÓN ARECES
L'objectiu d'aquesta Convocatòria és la concessió d'una dotació econòmica al Projecte de recerca desenvolupat per grups coordinats multidisciplinaris per obtenir coneixement nou sobre qualsevol aspecte de les malalties rares.
 
Termini exhaurit
EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
The EFSD/Lilly Programme aims to promote increased European diabetes research and to raise public awareness and political understanding of the magnitude and burden of the disease.
 
Termini exhaurit
FUNDACIÓN PFIZER
Pfizer supports the global healthcare community’s independent initiatives to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
 
Borses de viatge
Termini exhaurit
THE COMPANY OF BIOLOGISTS
DMM Conference Travel Grants are aimed at early-career researchers wanting to attend scientific meetings, conferences, workshops and courses relating to the areas of research covered by the journal.
 
Premis
Termini exhaurit
JOHN WILEY & SONS LIMITED
The Wiley Prize in Biomedical Sciences is intended to recognize breakthrough research in pure or applied life science research that is distinguished by its excellence, originality, and impact on our understanding of biological systems and processes.
 
Termini exhaurit
FUNDACIÓN ALIMERKA
Les tres categories dels premis manifesten la paradoxa de l'alimentació a la societat contemporània: d'una banda es reconeixen iniciatives exemplars en el camp de la nutrició i, d'altra banda, es premien experiències en l'àmbit de l'assistència alimentària a l'entorn proper i de lluita contra la gana i la malnutrició en països en desenvolupament.
 
Termini exhaurit
PSICOFUNDACION - FUNDACIÓN ESPAÑOLA PARA LA PROMOCIÓN Y EL DESARROLLO CIENTÍFICO Y PROFESIONAL DE LA PSICOLOGÍA
Amb l'objectiu de fomentar la iniciativa, la creativitat i la innovació dels joves psicòlegs espanyols i dels països llatinoamericans.
 
Termini exhaurit
GRETE LUNDBECK EUROPEAN BRAIN RESEARCH FOUNDATION
‘The Brain Prize’- is awarded to one or more scientists who have distinguished themselves by an outstanding contribution to European neuroscience and who are still active in research.
 
Recursos Humans
Termini exhaurit
COMISSIO EUROPEA
2 year fellowships to enhance the creative and innovative potential of experienced researchers wishing to diversify their individual competence in terms of skill acquisition at multi- or interdisciplinary level through advanced training, international, interdisciplinary and intersectoral mobility.
 
Termini exhaurit
FEHH - FUNDACION ESPAÑOLA DE HEMATOLOGIA Y HEMOTERAPIA
La FEHH convoca un programa de 10 beques per a gaudir en 2026: 9 de la FEHH, 1 en col·laboració amb el grup Espanyol de Leucemia Linfocítica Crónica (GELLC).
Les Ajudes van dirigides a socis de la Societat Espanyola d'Hematologia i Hemoteràpia (SEHH) que desitgin realitzar un projecte de recerca en un centre espanyol, en l'àmbit de les àrees que conformen l'especialitat d'Hematologia i Hemoteràpia.
 
Termini exhaurit
CANCER RESEARCH INSTITUTE
The CRI Irvington Postdoctoral Fellowship Program supports qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or cancer immunology.
 
Termini exhaurit
AES - AMERICAN EPILEPSY SOCIETY
This two-year award supports clinical research training in the field of epilepsy. It is hoped that this program, targeting fellows and new faculty, will foster the development of investigators interested in pursuing careers in patient-oriented research.
 
 
 
 
Articles
 
Morales-Avalos R*, Chiappe C, Ceniceros-Cantú C, Cienfuegos-Jiménez G, Garza-López J, Ortiz-García CF, Elizondo-Omaña RE, Guzmán-López S, Monllau JC, Sanchis-Alfonso V. Femoral maltorsion influences both patellofemoral and tibiofemoral contact pressures. A biomechanical evaluation. J ISAKOS . 2025; 12: 100866.
 
Matheu Fabra A*, Martínez Rodríguez JE, Beltran-Marmol B, Saint-Gerons Trecu M. Very late-onset neuromyelitis optica, a report of two cases. Arch Soc Esp Oftalmol 2025; 100(6): 367-371.
 
Butron-Bris B, Llamas-Velasco M, Armesto S, Sahuquillo-Torralba A, Pujol-Montcusi JA, Ruiz-Villaverde R, Martínez-López A, de la Cueva P, Romero-Maté A, Roustan G, Vilarrasa Rull E, Ferran M, Ovejero-Benito MC, Palomar-Moreno C, Navares M, Novalbos J, Abad-Santos F, Daudén E, de la Fuente H*. Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice. Actas Dermosifiliograf 2025: (en Premsa).
 
 
Hernández-Cacho A, García Gavilán J*, Atzeni A, Konstanti P, Belzer C, Vioque J, Corella D, Fitó Colomer M, Vidal J, Mela V, Liang L, Torres-Collado L, Coltell O, Babio N, Clish C, Hernando J, Martínez González M.A, Wang F, Moreno-Indias I, Ni J, Dennis C, Ruiz Canela M, Tinahones FJ, Hu FB, Salas Salvadó J*. Multi-omics approach identifies gut microbiota variations associated with depression. NPJ Biofilms Microbiomes . 2025; 11(1): 68.
 
Giménez-Arnau AM, Pinter A, Sondermann W, Reguiai Z, Woolf R, Lynde C, Legat FJ, Costanzo A, Silvestre JF, Mellerup N, Østerdal ML, Plohberger U, Ryttig L, Bauer A, trial investigators. Efficacy and safety of topical delgocitinib cream versus oral alitretinoin capsules in adults with severe chronic hand eczema (DELTA FORCE): a 24-week, randomised, head-to-head, phase 3 trial. Lancet 2025; 405(10490): 1676-1688.
 
Sala M*, Pascual S, Rota-Roca MR, Matilla AM, Campos M, Delgado M, Ferrer MT, Montero JL, González-Santiago JM, Guerrero A, Aracil C, Rodríguez-Lope C, Romero-Gutiérrez M, Sogbe M, Vázquez-Rodriguez S, Olmo JF, Mínguez B, Cortés-García L, Vallejo-Senra N, Unceta PR, Clos A, Díaz-Bethencourt D, Sánchez AG, Castro RQ, Bustamante J, Perelló C, Urquijo Ponce, Serra HA, Llamoza-Torres CJ, Montoliu S, Fernández-Marcos C, Guiberteau A, Hernández-Guerra M, Vergara M, Fernández-López AM, Valer López-Fando MP, Gutiérrez-García ML, Hernáez-Alsina T, Coll S, Cuyás B, Morillas MJ, Olmedo SR, Fernández-Bermejo M, Roget M, Ramos IC, Pacheco-Del Río G, Rifà R, Gacho PC, Barrio ML, Gómez Rubio M, Peñas I, Serra I, Cachero A, Reig M, Giraldez Á, Guerrero M, Segarra JX, Lledó JL, Díaz-González Á, Delgado C, Iñarrairaegui M, Rodríguez-González MM, Lazaro M, Bermúdez-Ramos M, Lué A, Molina E, Macías-Rodríguez MA, Rodriguez M, Chiminazzo V, Varela M*. Evolving epidemiology of HCC in Spain. JHEP Rep 2025; 7(5): 101336 (Acceptat).
 
Santibáñez M*, Núñez-Robainas A, Barreiro E, Expósito A, Agüero J, García-Rivero JL, Abascal B, Amado CA, Ruiz-Cubillán JJ, Fernández-Sobaler C, García-Unzueta M, Cifrián JM, Fernandez-Olmo I. Characterization of Systemic Oxidative Stress in Asthmatic Adults Compared to Healthy Controls and Its Association with the Oxidative Potential of Particulate Matter Collected Using Personal Samplers. Antioxidants 2025; 14(4): 385.
 
Lorenzo T*, Ngandu T, Lehtisalo J, Antikainen R, Gispert JD, Kemppainen N, Laatikainen T, Lindström J, Rinne J, Soininen H, Strandberg T, de la Torre R, Tuomilehto J, Solomon A, Kivipelto M. Associations of Prediabetes, Diabetes and Glucose-Related Markers With Cognition and Neuroimaging in a 2-Year Multidomain Lifestyle Randomised Controlled Trial. Diabetes Metab Res Rev . 2025; 41(5): e70053.
 
Medel-Lacruz B, Herrero A, Martín F, Herrero E, Luque FJ, Vázquez J*. Synthon-Based Strategies Exploiting Molecular Similarity and Protein-Ligand Interactions for Efficient Screening of Ultra-Large Chemical Libraries. J Chem Inf Model 2025: (en Premsa).
 
Munroe ES, Spicer A, Castellví-Font A, Zalucky A, Dianti J, Graham-Linck E, Talisa V, Urner M, Angus DC, Baedorf-Kassis E, Blette B, Bos LD, Buell KG, Casey JD, Calfee CS, Del Sorbo L, Estenssoro E, Ferguson ND, Giblon R, Granholm A, Harhay MO, Heath A, Hodgson C, Houle T, Jiang C, Kramer L, Lawler PR, Leligdowicz A, Li F, Liu K, Maiga A, Maslove D, Mcarthur C, Mcauley DF, Serpa-Neto A, Oosthuysen C, Perner A, Prescott HC, Rochwerg B, Sahetya S, Samoilenko M, Schnitzer ME, Seitz KP, Shah F, Shankar-Hari M, Sinha P, Slutsky AS, Qian ET, Webb SA, Young PJ, Zampieri FG, Zarychanski R, Fan E, Semler MW, Churpek M, Goligher EC*, Evidence-based Individualized Treatment Effects (EvITE) Group. Evidence-based personalised medicine in critical care: a framework for quantifying and applying individualised treatment effects in patients who are critically ill. Lancet Resp. Med. 2025; 13(6): 556-568.
 
Dierssen-Sotos T, Gómez Acebo I, Alonso-Molero J*, Pérez Gómez B, Guevara M, Amiano P, Castaño Vinyals G, Marcos-Delgado A, Mirones M, Obón Santacana M, Fernández Tardón G, Molina-Barceló A, Bayo J, Sanvisens A, Fernández-Ortíz M, Fernández-Villa T, Espinosa A, Aizpurua A, Ardanaz E, Aaragonés N, Kogevinas M, Pollán M, Llorca J. The influence of socio-economic status on the fulfilment of Saint-Gallen recommendations for early-stage breast cancer. Sci Rep 2025; 15(1): 14129.
 
Atzeni A*, Hernández-Cacho A, Khoury N, Babio N, Belzer C, Vioque J, Corella D, Fitó Colomer M, Clish C, Vidal J, Konstanti P, Gonzales-Palacios S, Coltell O, Goday A, Moreno-Indias I, Carlos-Chillerón S, Ruiz Canela M, Tinahones FJ, Hu FB, Salas Salvadó J*. The link between ultra-processed food consumption, fecal microbiota, and metabolomic profiles in older mediterranean adults at high cardiovascular risk. Nutr J 2025; 24(1): 62.
 
Larruy-García A, Miguel-Berges ML*, Torre IR, Pastor-Villaescusa B, Leis R, Babio N, Navas-Carretero S, Corella D, Pérez-Vega KA, Gil-Campos M, Picáns-Leis R, García-Gavilán J, Flores-Barrante P, Martinez JA, Llorente-Cantarero FJ, Vázquez-Cobela R, Paz-Graniel I, Ayala-Marín AM, Jurado-Castro JM, de la Torre-Aguilar MJ, Gheorghita I, Moreno LA, De Miguel-Etayo P, CORAL Study group. Cross-sectional associations between Mediterranean diet and body composition in preschool children. CORAL study. Pediatr Obes 2025; 20(7): e70014.
 
de Castro J*, Alonso-Fernández P, Castrodeza JJ, Gayete A, Hernando F, Martínez-Olmos J, Massuti B, Paz-Ares L, Sisó-Almirall A, Vicente D, Molins L. Monitoring of the oncological process for lung cancer in Spain: an expert consensus report. Clin Transl Oncol 2025: (en Premsa).
 
Ginés A, González-Lucena G, Gamba C, Bailez A, Ruiz-Riquelme P*, Martínez-Lozano JA. Manchester oxford foot questionnaire in foot and ankle Spanish patients: Transcultural adaption and validation. Foot Ankle Surg 2025: (en Premsa).
 
Abbad D*, Carballo-Casla A*, Beridze G, López-García E, Rodríguez-Artalejo F, Sala M, Comas M, Vetrano DL, Calderón-Larrañaga A. Dietary patterns and accelerated multimorbidity in older adults. Nat Aging. 2025: (en Premsa).
 
Thorvaldsdottir B, Mansouri L, Sutton LA, Nadeu-Prat F, Meggendorfer M, Parker H, Brieghel C, Laidou S, Moia R, Rossi D, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfò L, Mattsson M, Davis Z, Baliakas P, Rapado I, Miras F, Martínez-López J, de la Serna J, Hernández-Rivas JM, Larráyoz MJ, Calasanz MJ, Smedby KE, Espinet B, Puiggros A, Bullinger L, Bosch F, Tazón-Vega B, Baran-Marszak F, Oscier D, Nguyen-Khac F, Zenz T, Terol MJ, Cuneo A, Hernández-Sánchez M, Pospisilova S, Gaidano G, Niemann CU, Campo E, Strefford JC, Ghia P, Stamatopoulos K, Rosenquist R*. ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker. Leukemia 2025; 39(7): 1650-1660.
 
Pérez-Lamas L, Segura-Díaz A, García-Delgado R, Álvarez-Larran A, Senín MA, Mora-Casterá E, Fox ML, Pastor-Galán I, Azaceta G, Garrido-Paniagua S, Perez-Lopez R, Trejos-Carvajal DM, Angona A, Albo-López C, Lorente-Alegre P, Vara M, Vera-Goñi JA, De Miguel-Llorente D, Fernández-Rodríguez A, Marin-Sanchez A, Hernando-Megido A, Gómez-Casares MT, Stuckey R, Carreño-Tarragona G, De Las Heras Rodríguez N, Xicoy B, Pérez-Encinas M, Mata-Serna R, Núñez Martin-Buitrago L, Ferrer-Marín F, Amer-Salas N, Guillén-Rienda C, Vélez P, Lamarca-Eraso L, Martin S, Luts-Khoroz I, De Cabo-López E, Gil A, Martín-Consuegra Ramos S, Marco-de Lucas F, Otero Martinez-Fornes MJ, Martin Mateos ML, Arquero T, Cabezudo-Pérez E, López-Gómez LA, Martínez-Hellin A, Tejedor A, Herrera de Pablo E, Mata-Vazquez MI, Castillo-Valero I, Fernández MJ, Aguilar C, Santaliestra M, García-Menchon A, Navas B, Duran MA, Pérez-Sala M, Hernández-Santamaría T, Muñoz-Jarreño MA, Dávila-Valls J, Torres-Jiménez W, Gonzálvez-Fernández JA, Torres-Mantilla HA, Cobo-Rodríguez T, Abuin A, Perez F, Osorio-Prendes S, Beneit-Villena P, Peralta R, Herrera F, Cañamero-Giro E, Jiménez-Bárcenas R, Gasior M, De Villambrosía S, Tercero-Mora Rodriguez MT, Menéndez-Cuevas M, Ruiz BC, Fonseca-Santos M, Garcés-Piquer S, De La Puerta R, Lorenzo-Vizcaya Á, Hernández-Boluda JC*, García-Gutiérrez V*. Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study. Blood Cancer J 2025; 15(1): 67.
 
Akinci M, Aguilar-Dominguez P, Palpatzis E, Shekari M, García-Prat M, Deulofeu C, Fauria K*, Garcia-Aymerich J, Gispert JD, Suarez-Calvet M, Grau-Rivera O, Sánchez-Benavides G, Arenaza-Urquijo EM*, ALFA study. Physical activity changes during midlife link to brain integrity and amyloid burden. Alzheimers Dement 2025; 21(5): e70007.
 
Giménez-Arnau AM*, Ferrucci S, Ben-Shoshan M, Mikol V, Lucats L, Sun I, Mannent L, Gereige J. Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria: The RILECSU Phase 2 Randomized Clinical Trial. JAMA Dermatol 2025; 161(7): 679-687.
 
 
Institut Hospital del Mar d'Investigacions Mèdiques
Tel: 93 316 04 00
Doctor Aiguader, 88
08003 Barcelona
Seguiu-nos a:
Twitter
Youtube
En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM ([email protected]) tot indicant la paraula “baixa base de dades” a l’assumpte.
Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM ([email protected]).